A Mathematical Model of the Transition from Normal Hematopoiesis to the Chronic and Accelerated-Acute Stages in Myeloid Leukemia Research Paper, March 8, 2020 / Lorand Gabriel Parajdi
Published in MDPI Mathematics 8(3), 376, DOI: 10.3390/math8030376, 2020.
The full paper is available on the MDPI Mathematics website: https://www.mdpi.com/2227-7390/8/3/376/htm
Authors: Lorand Gabriel Parajdi1, Radu Precup1, Eduard Alexandru Bonci2,3 and Ciprian Tomuleasa4
1 Department of Mathematics, “Babeş–Bolyai” University, Cluj-Napoca, Romania 2 Department of Oncology, “Iuliu Haţieganu” University of Medicine and Pharmacy, Cluj-Napoca, Romania 3 Department of Surgical Oncology, “Ion Chiricuţă” Clinical Cancer Center, Cluj-Napoca, Romania 4 Department of Hematology, “Ion Chiricuţă” Clinical Cancer Center, Cluj-Napoca, Romania
Abstract: A mathematical model given by a two-dimensional differential system is introduced in order to understand the transition process from the normal hematopoiesis to the chronic and accelerated-acute stages in chronic myeloid leukemia. A previous model of Dingli and Michor is refined by introducing a new parameter in order to differentiate the bone marrow microenvironment sensitivities of normal and mutant stem cells. In the light of the new parameter, the system now has three distinct equilibria corresponding to the normal hematopoietic state, to the chronic state, and to the accelerated-acute phase of the disease. A characterization of the three hematopoietic states is obtained based on the stability analysis. Numerical simulations are included to illustrate the theoretical results.
Keywords: Mathematical modeling; Dynamic system; Steady state; Stability; Hematopoiesis; Chronic myeloid leukemia; Stem cells.
Cite As: Parajdi LG, Precup R, Bonci EA, Tomuleasa C. A mathematical model of the transition from normal hematopoiesis to the chronic and accelerated-acute stages in myeloid leukemia. Mathematics. 2020; 8(3):376.
This article was awarded by UEFISCDI.gov in the competition “The Awards of the Research Results Published in 2020” (PRECISI 2020). For the results see: https://uefiscdi.gov.ro/resource-824946-precisi_2020_lista-1
References:
1. Rubinow, S.I.; Lebowitz, J.L. A mathematical model of neutrophil production and control in normal man. J. Math. Biol. 1975, 1, 187–225. [Article]
2. Rubinow, S.I.; Lebowitz, J.L. A mathematical model of the acute myeloblastic leukemic state in man. Biophys. J. 1976, 16, 897–910. [Article]
3. Mackey, M.C.; Glass, L. Oscillation and chaos in physiological control systems. Science 1977, 197, 287–289. [CrossRef]
4. Mackey, M.C. Unified hypothesis of the origin of aplastic anemia and periodic hematopoiesis. Blood 1978, 51, 941–956. [CrossRef]
5. Djulbegovic, B.; Svetina, S. Mathematical model of acute myeloblastic leukaemia: An investigation of the relevant kinetic parameters. Cell Prolif. 1985, 18, 307–319. [CrossRef]
6. Fokas, A.S.; Keller, J.B.; Clarkson, B.D. Mathematical model of granulocytopoiesis and chronic myelogenous leukemia. Cancer Res. 1991, 51, 2084–2091. [Google Scholar]
7. Neiman, B. A Mathematical Model of Chronic Myelogenous Leukemia; Oxford University: Oxford, UK, 2000; Available online: https://core.ac.uk/download/files/69/96488.pdf (accessed on 10 May 2019).
8. Andersen, L.K.; Mackey, M.C. Resonance in periodic chemotherapy: A case study of acute myelogenous leukemia. J. Theor. Biol. 2001, 209, 113–130. [CrossRef]
9. Colijn, C.; Mackey, M.C. A mathematical model of hematopoiesis-I. Periodic chronic myelogenous leukemia. J. Theor. Biol. 2005, 237, 117–132. [CrossRef]
10. Adimy, M.; Crauste, F.; Ruan, S. A mathematical study of the hematopoiesis process with applications to chronic myelogenous leikemia. SIAM J. Appl. Math. 2005, 65, 1328–1352. [CrossRef]
11. Dingli, D.; Michor, F. Successful therapy must eradicate cancer stem cells. Stem Cells 2006, 24, 2603–2610. [CrossRef]
12. Kim, P.S.; Lee, P.P.; Levy, D. Dynamics and potential impact of the immune response to chronic myelogenous leukemia. PLoS Comput. Biol. 2008, 4, e1000095. [CrossRef]
13. Cucuianu, A.; Precup, R. A hypothetical-mathematical model of acute myeloid leukemia pathogenesis. Comput. Math. Methods Med. 2010, 11, 49–65. [CrossRef]
14. Doumic-Jauffret, M.; Kim, P.S.; Perthame, B. Stability analysis of a simplified yet complete model for chronic myelogenous leukemia. Bull. Math. Biol. 2010, 72, 1732–1759. [CrossRef]
15. Komarova, N.L. Mathematical modeling of cyclic treatments of chronic myeloid leukemia. Math. Biosci. Eng. 2011, 8, 289–306. [Google Scholar]
16. Stiehl, T.; Marciniak-Czochra, A. Mathematical modelling of leukemogenesis and cancer stem cell dynamics. Math. Mod. Nat. Phenom. 2012, 7, 166–202. [CrossRef]
17. MacLean, A.L.; Lo Celso, C.; Stumpf, M.P.H. Population dynamics of normal and leukaemia stem cells in the haematopoietic stem cell niche show distinct regimes where leukaemia will be controlled. J. R. Soc. Interfaces 2013, 10, 20120968. [CrossRef]
18. MacLean, A.L.; Filippi, S.; Stumpf, M.P.H. The ecology in the hematopoietic stem cell niche determines the clinical outcome in chronic myeloid leukemia. Proc. Natl. Acad. Sci. USA 2014, 111, 3882–3888. [CrossRef]
19. Radulescu, I.R.; Candea, D.; Halanay, A. A study on stability and medical implications for a complex delay model for CML with cell competition and treatment. J. Theor. Biol. 2014, 363, 30–40. [CrossRef]
20. Bianca, C.; Pennisi, M.; Motta, S.; Ragusa, M.A. Immune system network and cancer vaccine. AIP Conf. Proc. 2011, 1389, 945–948. [Google Scholar]
21. Bianca, C.; Pappalardo, F.; Pennisi, M.; Ragusa, M.A. Persistence analysis in a Kolmogorov-type model for cancer-immune system competition. AIP Conf. Proc. 2013, 1558, 1797–1800. [Google Scholar]
22. Ragusa, M.A.; Russo, G. ODEs approaches in modeling fibrosis: Comment on “Towards a unified approach in the modeling of fibrosis: A review with research perspectives” by Martine Ben Amar and Carlo Bianca. Phys. Life Rev. 2016, 17, 112–113. [CrossRef]
23. Vincent, P.C.; Rutzen-Loesevitz, L.; Tibken, B.; Heinze, B.; Hofer, E.P.; Fliedner, T.M. Relapse in chronic myeloid leukemia after bone marrow transplantation: Biomathematical modeling as a new approach to understanding pathogenesis. Stem Cells 1999, 17, 9–17. [CrossRef]
24. De Conde, R.; Kim, P.S.; Levy, D.; Lee, P.P. Post-transplantation dynamics of the immune response to chronic myelogenous leukemia. J. Theor. Biol. 2005, 236, 39–59. [CrossRef]
25. Kim, P.S.; Lee, P.P.; Levy, D. Mini-Transplants for Chronic Myelogenous Leukemia: A Modeling Perspective, Biology and Control Theory: Current Challenges; Lecture Notes in Control and Information Sciences; Springer: Berlin/Heidelberg, Germany, 2007; Volume 357, pp. 3–20. [Google Scholar]
26. Marciniak-Czochra, A.; Stiehl, T. Mathematical models of hematopoietic reconstitution after stem cell transplantation. In Model Based Parameter Estimation: Theory and Applications; Bock, H.G., Carraro, T., Jaeger, W., Koerkel, S., Rannacher, R., Schloeder, J.P., Eds.; Springer: Berlin/Heidelberg, Germany, 2007; pp. 191–206. [Google Scholar]
27. Precup, R.; Arghirescu, S.; Cucuianu, A.; Serban, M. Mathematical Modeling of cell dynamics after allogeneic bone marrow transplantation. Int. J. Biomath. 2012, 5, 1–18. [CrossRef]
28. Precup, R.; Serban, M.A.; Trif, D. Asymptotic stability for a model of cellular dynamics after allogeneic bone marrow transplantation. Nonlinear Dyn. Syst. Theory 2013, 13, 79–92. [Google Scholar]
29. Precup, R. Mathematical understanding of the autologous stem cell transplantation. Ann. Tiberiu Popoviciu Semin. Funct. Equ. Approx. Convexity 2012, 10, 155–167. [Google Scholar]
30. Stiehl, T.; Ho, A.; Marciniak-Czochra, A. The impact of CD34+ cell dose on engraftment after SCTs: Personalized estimates based on mathematical modeling. Bone Marrow Transpl. 2014, 49, 30–37. [CrossRef]
31. Afenya, E. Mathematical models for cancer and their relevant insights. In Handbook of Cancer Models with Applications; Tan, W.Y., Hanin, L., Eds.; World Scientific: Hackensack, NJ, USA, 2008. [Google Scholar]
32. Michor, F. Mathematical models of cancer stem cells. J. Clin. Oncol. 2008, 26, 2854–2861. [CrossRef]
33. Foley, C.; Mackey, M.C. Dynamic hematological disease: A review. J. Math. Biol. 2009, 58, 285–322. [CrossRef]
34. Clapp, G.; Levy, D. A review of mathematical models for leukemia and lymphoma. Drug Discov. Today Dis. Models 2015, 16, 1–6. [CrossRef]
35. Jilkine, A.; Gutenkunst, R. Effect of dedifferentiation on time to mutation acquisition in stem cell-driven cancers. PLoS Comput. Biol. 2014, 10, e1003481. [CrossRef]
36. Driessens, G.; Beck, B.; Caauwe, A.; Simons, B.; Blanpain, C. Defining the mode of tumour growth by clonal analysis. Nature 2012, 488, 527–530. [CrossRef]
37. Klein, A.; Simons, B. Universal patterns of stem cell fate in cycling adult tissues. Development 2011, 138, 3103–3111. [Article]
38. Lopez-Garcia, C.; Klein, A.; Simons, B.; Winton, D. Intestinal stem cell replacement follows a pattern of neutral drift. Science 2010, 330, 822–825. [Article]
39. Snippert, H.; van der Flier, L.; Sato, T.; van Es, J.; van den Born, M.; Kroon-Veenboer, C.; Barker, N.; Klein, A.; van Rheenen, J.; Simons, B.; et al. Intestinal crypt homeostasis results from neutral competition between symmetrically dividing Lgr5 stem cells. Cell 2010, 143, 134–144. [Article]
40. Gou, X.C.; Kong, D.; Tang, X. Contradictory relationships between cancer and normal cells and implications for anti-cancer therapy. Asian Pac. J. Cancer Prev. 2015, 16, 5143–5147. [Article]
41. Precup, R.; Serban, M.A.; Trif, D.; Cucuianu, A. A planning algorithm for correction therapies after allogeneic stem cell transplantation. J. Math. Model. Algorithm 2012, 11, 309–323. [Article]
42. Michor, F.; Hughes, T.P.; Iwasa, Y.; Branford, S.; Shah, N.P.; Sawyers, C.L.; Nowak, M.A. Dynamics of chronic myeloid leukaemia. Nature 2005, 435, 1267–1270. [Article]
43. Howard, M.; Hamilton, P.; Britton, R. Haematology; Churchill Livingstone: London, UK, 2013; pp. 10–120. [Google Scholar]
44. Young, N. Clinical Hematology; Mosby Elsevier: Philadelphia, PA, USA, 2006; pp. 1035–1456. [Google Scholar]
45. Kaushansky, K.; Lichtman, M.A.; Beutler, E.; Kipps, T.J.; Seligsohn, U.; Prchal, J.T. Williams Hematology; McGraw-Hill Medical: New York, NY, USA, 2010; pp. 1150–2439. [Google Scholar]
46. Kawamoto, H.; Wada, H.; Katsura, Y. A revised scheme for developmental pathways of hematopoietic cells: The myeloid-based model. Int. Immunol. 2010, 22, 65–70. [Article]
47. Abkowitz, J.L. Evidence that the number of hematopoietic stem cells per animal is conserved in mammals. Blood 2002, 100, 2665–2667. [Article]
48. Ramalingam, P.; Poulos, M.; Butler, J. Regulation of the hematopoietic stem cell lifecycle by the endothelial niche. Comput. Curr. Opin. Hematol. 2017, 24, 289–299. [Article]
49. Zon, L. Intrinsic and extrinsic control of haematopoietic stem-cell self-renewal. Nature 2008, 453, 306–313. [Article]
50. Arber, D.; Orazi, A.; Hasserjian, R.; Thiele, J.; Borowitz, M.; Le Beau, M.; Bloomfield, C.; Cazzola, M.; Vardiman, J. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 2016, 127, 2391–2405. [Article]
51. Roeder, I.; d’Inverno, M. New experimental and theoretical investigations of hematopoietic stem cells and chronic myeloid leukemia. Blood Cells Mol. Dis. 2009, 43, 88–97. [Article]
52. Hemminki, K.; Jiang, Y. Familial myeloid leukemias from the Swedish Family-Cancer Database. Leuk. Res. 2002, 26, 611–613. [Article]
53. Kantarjian, H.; O’Brien, S.; Jabbour, E.; Garcia-Manero, G.; Quintas-Cardama, A.; Shan, J.; Rios, M.; Ravandi, F.; Faderl, S.; Kadia, T.; et al. Improved survival in chronic myeloid leukemia since the introduction of imatinib therapy: A single-institution historical experience. Blood 2012, 119, 1981–1987. [Article]
54. Thomas, E. Marrow transplantation for the treatment of chronic myelogenous leukemia. Ann. Intern. Med. 1986, 104, 155–163. [Article]
55. Alenzi, F.Q.; Alenazi, B.Q.; Ahmad, S.Y.; Salem, M.L.; Al-Jabri, A.A.; Wyse, R.K.H. The haemopoietic stem cell: Between apoptosis and self renewal. Yale J. Biol. Med. 2009, 82, 7–18. [Google Scholar]
56. Cisneros, T.; Dillard, D.; Castro, M.; Arredondo-Guerrero, J.; Krams, S.; Esquivel, C.; Martinez, O. The role of natural killer cells in recognition and killing of stem cells and stem cell-derived hepatoblasts. Am. J. Transplant 2017, 17 (Suppl. 3), 115. [Google Scholar]
57. Domen, J. The role of apoptosis in regulating hematopoietic stem cell numbers. Apoptosis 2001, 6, 239–252. [Article]
58. Riether, C.; Schürch, C.M.; Ochsenbein, A.F. Regulation of hematopoietic and leukemic stem cells by the immune system. Cell Death Differ. 2015, 22, 187–198. [Article]
59. Vivier, E.; Tomasello, E.; Baratin, M.; Walzer, T.; Ugolini, S. Functions of natural killer cells. Nat. Immunol. 2008, 9, 503–510. [Article]
60. Kaplan, D.; Glass, L. Understanding Nonlinear Dynamics; Springer: New York, NY, USA, 1995. [Google Scholar]
61. Coddington, E.A.; Levinson, N. Theory of Ordinary Differential Equations; Tata McGraw-Hill: New Delhi, India, 1972. [Google Scholar]
62. Jones, D.S.; Plank, M.J.; Sleeman, B.D. Differential Equations and Mathematical Biology; CRC Press: London, UK, 2010. [Google Scholar]
63. Stine, R.; Matunis, E. Stem cell competition: Finding balance in the niche. Trends Cell Biol. 2013, 23, 357–364. [Article]
64. Catlin, S.; Busque, L.; Gale, R.; Guttorp, P.; Abkowitz, J. The replication rate of human hematopoietic stem cells in vivo. Blood 2011, 117, 4460–4466. [Article]
65. Wilson, A.; Laurenti, E.; Oser, G.; van der Wath, R.; Blanco-Bose, W.; Jaworski, M.; Offner, S.; Dunant, C.; Eshkind, L.; Bockamp, E.; et al. Hematopoietic stem cells reversibly switch from dormancy to self-renewal during homeostasis and repair. Cell 2008, 135, 1118–1129. [Article]
66. Sieburg, H.; Rezner, B.; Muller-Sieburg, C. Predicting clonal self-renewal and extinction of hematopoietic stem cells. Proc. Natl. Acad. Sci. USA 2011, 108, 4370–4375. [Article]
67. Sieburg, H.; Cattarossi, G.; Muller-Sieburg, C. Lifespan differences in hematopoietic stem cells are due to imperfect repair and unstable mean-reversion. PLoS Comput. Biol. 2013, 9, e1003006. [Article]
68. Enriquez-Navas, P.; Kam, Y.; Das, T.; Hassan, S.; Silva, A.; Foroutan, P.; Ruiz, E.; Martinez, G.; Minton, S.; Gillies, R.; et al. Exploiting evolutionary principles to prolong tumor control in preclinical models of breast cancer. Sci. Transl. Med. 2016, 8, 327ra24. [Article]
69. Gerlinger, M.; Rowan, A.; Horswell, S.; Larkin, J.; Endesfelder, D.; Gronroos, E.; Martinez, P.; Matthews, N.; Stewart, A.; Tarpey, P.; et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N. Engl. J. Med. 2012, 366, 883–892. [Article]